Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma.
Duffy AG, Ma C, Ulahannan SV, Rahma OE, Makarova-Rusher O, Cao L, Yu Y, Kleiner DE, Trepel J, Lee MJ, Tomita Y, Steinberg SM, Heller T, Turkbey B, Choyke PL, Peer CJ, Figg WD, Wood BJ, Greten TF. Duffy AG, et al. Among authors: greten tf. Clin Cancer Res. 2017 Aug 15;23(16):4633-4641. doi: 10.1158/1078-0432.CCR-16-3171. Epub 2017 May 2. Clin Cancer Res. 2017. PMID: 28465443 Free PMC article. Clinical Trial.
Immunotherapy of hepatocellular carcinoma.
Greten TF, Manns MP, Korangy F. Greten TF, et al. J Hepatol. 2006 Dec;45(6):868-78. doi: 10.1016/j.jhep.2006.09.004. Epub 2006 Sep 29. J Hepatol. 2006. PMID: 17046096 Review. No abstract available.
Sorafenib in advanced hepatocellular carcinoma.
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Llovet JM, et al. Among authors: greten tf. N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857. N Engl J Med. 2008. PMID: 18650514 Free article. Clinical Trial.
S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F. Zhao F, et al. Among authors: greten tf. Immunology. 2012 Jun;136(2):176-83. doi: 10.1111/j.1365-2567.2012.03566.x. Immunology. 2012. PMID: 22304731 Free PMC article.
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
Duffy A, Rahma O, Greten TF. Duffy A, et al. Among authors: greten tf. Int J Cancer. 2013 Apr 1;132(7):1718. doi: 10.1002/ijc.27805. Epub 2012 Sep 18. Int J Cancer. 2013. PMID: 22930464 Free PMC article. No abstract available.
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.
Duffy A, Zhao F, Haile L, Gamrekelashvili J, Fioravanti S, Ma C, Kapanadze T, Compton K, Figg WD, Greten TF. Duffy A, et al. Among authors: greten tf. Cancer Immunol Immunother. 2013 Feb;62(2):299-307. doi: 10.1007/s00262-012-1332-3. Epub 2012 Aug 22. Cancer Immunol Immunother. 2013. PMID: 23011590 Free PMC article.
259 results